Related Experiment Video
Updated: Jun 30, 2026
11:42
Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
Published on: November 4, 2019
Hematopoietic Cell Fate Reprogramming in the Context of Pathological Processes and Translational Opportunities
1Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Cellular Reprogramming
|June 29, 2026
Summary
Hematopoietic cell fate reprogramming, driven by transcription factors, can convert cell types like B cells into macrophages. This process offers insights into cellular identity and potential cancer therapies.
Area of Science:
- Hematology
- Cell Biology
- Immunology
Background:
- The hematopoietic system comprises diverse cell lineages with specialized immune functions.
- Cell fate conversion involves altering lineage-specific transcription factors to reprogram cells.
Purpose of the Study:
- To review the characteristics and criteria defining hematopoietic cell fate conversion.
- To illustrate molecular mechanisms using CCAAT/enhancer binding proteins as an example.
- To explore disease implications and therapeutic strategies involving cell fate reprogramming.
Main Methods:
- Review of existing literature on hematopoietic cell fate conversion.
- Analysis of transcription factor-mediated reprogramming pathways (transdifferentiation, dedifferentiation, lineage diversion).
- Case study using CCAAT/enhancer binding proteins converting B cells to macrophages and neutrophils.
Main Results:
- Perturbation of transcription factors can induce cell fate changes.
- CCAAT/enhancer binding proteins efficiently convert B cells into macrophages and neutrophils.
- Lineage infidelity in leukemia represents a disease-associated phenomenon.
Conclusions:
- Hematopoietic cell fate reprogramming provides insights into cellular identity specification.
- Controlled reprogramming systems offer platforms for in vitro screening and functional studies.
- Cell fate conversion presents translational opportunities in immunity and cancer treatment.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:21Lineage Commitment
Commitment is the process whereby stem cells:
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:28Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.